(Q45755289)

15 December 2017

title

Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRA. (English)

1 reference

15 December 2017

1 reference

A Nakajima

1

1 reference

15 December 2017

E Inoue

2

1 reference

15 December 2017

E Tanaka

3

1 reference

15 December 2017

G Singh

4

1 reference

15 December 2017

E Sato

5

1 reference

15 December 2017

D Hoshi

6

1 reference

15 December 2017

K Shidara

7

1 reference

15 December 2017

M Hara

8

1 reference

15 December 2017

S Momohara

9

1 reference

15 December 2017

A Taniguchi

10

1 reference

15 December 2017

N Kamatani

11

1 reference

15 December 2017

H Yamanaka

12

1 reference

15 December 2017

publication date

1 January 2010

1 reference

15 December 2017

Scandinavian Journal of Rheumatology

published in

1 reference

15 December 2017

volume

39

1 reference

15 December 2017

issue

5

1 reference

15 December 2017

page(s)

360-367

1 reference

15 December 2017

COURSE AND PROGNOSIS IN RHEUMATOID ARTHRITIS. A FURTHER REPORT.

cites work

1 reference

https://api.crossref.org/works/10.3109%2F03009741003604542

No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009741003604542

Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009741003604542

Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009741003604542

All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009741003604542

The widening mortality gap between rheumatoid arthritis patients and the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009741003604542

Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009741003604542

Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009741003604542

Mortality of rheumatoid arthritis in Japan: a longitudinal cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009741003604542

Increased risk of tuberculosis in patients with rheumatoid arthritis in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009741003604542

Validation of a Japanese version of the Stanford Health Assessment Questionnaire in 3,763 patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009741003604542

Bucillamine mechanism inhibiting IL-1beta-induced VEGF production from fibroblast-like synoviocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009741003604542

National databases and rheumatology research I: longitudinal databases in Scandinavia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009741003604542

Nine-year follow-up of a survey on smoking habits in Florence (Italy): higher mortality among non-responders.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009741003604542

Patterns of cardiovascular risk in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009741003604542

Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009741003604542

A novel single-nucleotide polymorphism at the 5'-flanking region of SAA1 associated with risk of type AA amyloidosis secondary to rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009741003604542

Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009741003604542

10.3109/03009741003604542

21 January 2018

Identifiers

DOI

1 reference

15 December 2017

PubMed ID

20476859

1 reference

15 December 2017